Skip to main content
OpenTrials

Clinical trial condition

Mesothelioma

Explore clinical trials studying Mesothelioma. Study availability and eligibility vary by location and protocol.

189 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Mesothelioma trial results

Completed

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

NCT00061477

Conditions
Adenoma, Mesothelioma, Neoplasms, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

NCT06097728

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Research Site Santa Rosa, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Atlanta, Georgia, United States
View all 151 locations
View Trial Details
Active, Not Recruiting

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

NCT02414269

Conditions
Adenoma, Breast Cancer, Breast Diseases, +21 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow-Up) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow-Up) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent and Follow-Up) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

NCT04857372

Conditions
Adenoma, Mesothelioma, Neoplasms, +3 more
Locations
  • University of California LA Los Angeles, California, United States
  • Uni of Chi Medi Ctr Hema and Onco Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

NCT00715611

Conditions
Adenoma, Mesothelioma, Neoplasms, +3 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
View Trial Details

Related conditions